🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184
This study is designed to compare the number of infusion reactions to treat...
Status
Completed
Location
St.Joseph Heritage Care
Start Date
2020-03-25
Trial ID
NCT04189588
Treatments Being Tested
This study is being conducted to demonstrate the superiority in progression...
Status
Completed
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01580228
Treatments Being Tested
A Phase 3 (extension) clinical trial to examine the efficacy of IPI-145 (du...
Status
Completed
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT02049515
Treatments Being Tested
To study the safety and side effects of Ofatumumab in the treatment of chro...
Status
Completed
Location
Mayo Clinic Cancer Center
Start Date
2012-11-14
Trial ID
NCT01680965
Treatments Being Tested
The goal of this clinical trial is to show that incorporating ofatumumab in...
Status
Completed
Location
University of California, San Francisco
Start Date
2012-05-25
Trial ID
NCT01555541
Treatments Being Tested
This was an observational, non-interventional, real world study involving s...
Status
Completed
Location
Novartis
Start Date
2024-02-09
Trial ID
NCT06854341
The aim of this study was to assess physician and patient satisfaction with...
Status
Completed
Location
Novartis
Start Date
2026-01-22
Trial ID
NCT07504783
This is an open-label, single-arm, multicentre prospective pilot study to a...
Status
Recruiting
Location
Tangdu Hospital
Start Date
2022-06-28
Trial ID
NCT05504694
Treatments Being Tested
The purpose of this study is to: Investigate the Overall Response Rate (ORR...
Status
Terminated
Location
Dartmouth-Hitchcock Medical Center
Start Date
2010-07
Trial ID
NCT01119794
Treatments Being Tested